303 related articles for article (PubMed ID: 31190159)
1. Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.
Dixit A; Mehta R; Singh AK
Cell Mol Neurobiol; 2019 Oct; 39(7):901-915. PubMed ID: 31190159
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in human Parkinson's disease research.
Licker V; Kövari E; Hochstrasser DF; Burkhard PR
J Proteomics; 2009 Nov; 73(1):10-29. PubMed ID: 19632367
[TBL] [Abstract][Full Text] [Related]
3. Brain-Biomarker Changes in Body Fluids of Patients with Parkinson's Disease.
Cocco C; Manai AL; Manca E; Noli B
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446110
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid protein biomarkers in Parkinson's disease.
Faizan M; Sachan N; Verma O; Sarkar A; Rawat N; Pratap Singh M
Clin Chim Acta; 2024 Mar; 556():117848. PubMed ID: 38417781
[TBL] [Abstract][Full Text] [Related]
5. Proteins and Transcriptional Dysregulation of the Brain Extracellular Matrix in Parkinson's Disease: A Systematic Review.
Rike WA; Stern S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108598
[TBL] [Abstract][Full Text] [Related]
6. Differential proteomics analysis of mononuclear cells in cerebrospinal fluid of Parkinson's disease.
Xing L; Wang D; Wang L; Lan W; Pan S
Int J Clin Exp Pathol; 2015; 8(11):15462-6. PubMed ID: 26823915
[TBL] [Abstract][Full Text] [Related]
7. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.
Srivastava G; Singh K; Tiwari MN; Singh MP
Expert Rev Proteomics; 2010 Feb; 7(1):127-39. PubMed ID: 20121482
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein and Parkinson's disease: a proteomic view.
Fasano M; Lopiano L
Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
[TBL] [Abstract][Full Text] [Related]
9. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.
van Dijk KD; Teunissen CE; Drukarch B; Jimenez CR; Groenewegen HJ; Berendse HW; van de Berg WD
Neurobiol Dis; 2010 Sep; 39(3):229-41. PubMed ID: 20451609
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease.
Raghunathan R; Turajane K; Wong LC
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012563
[TBL] [Abstract][Full Text] [Related]
12. Biomarker discovery in neurodegenerative diseases: a proteomic approach.
Shi M; Caudle WM; Zhang J
Neurobiol Dis; 2009 Aug; 35(2):157-64. PubMed ID: 18938247
[TBL] [Abstract][Full Text] [Related]
13. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
Singh MP; Patel S; Dikshit M; Gupta YK
Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study.
Boerger M; Funke S; Leha A; Roser AE; Wuestemann AK; Maass F; Bähr M; Grus F; Lingor P
Parkinsonism Relat Disord; 2019 Jun; 63():3-9. PubMed ID: 30876839
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.
Ren R; Sun Y; Zhao X; Pu X
Clin Chem Lab Med; 2015 Sep; 53(10):1495-506. PubMed ID: 25581757
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based Detection.
Kruse N; Mollenhauer B
Methods Mol Biol; 2019; 1948():59-68. PubMed ID: 30771170
[TBL] [Abstract][Full Text] [Related]
18. Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: A systematic review of proteomics studies.
Chelliah SS; Bhuvanendran S; Magalingam KB; Kamarudin MNA; Radhakrishnan AK
Ageing Res Rev; 2022 Jan; 73():101514. PubMed ID: 34798300
[TBL] [Abstract][Full Text] [Related]
19. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
Williams SM; Schulz P; Sierks MR
Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
[TBL] [Abstract][Full Text] [Related]
20. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG
J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
